Pumping iron for a stronger heart: can resistance training reverse muscle loss in seniors?
NCT ID NCT06785168
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 7 times
Summary
This study tests whether an 8-week machine-based resistance training program can improve muscle strength and physical function in older adults (60+) who have both chronic heart failure and sarcopenia (age-related muscle loss). Researchers will measure handgrip strength and sit-to-stand speed before and after the program. The goal is to find a safe, practical exercise approach for this vulnerable group.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Machine-based resistance training
- What this could lead to
- If it works, this could point toward a simple, drug-free way to help older heart failure patients regain muscle strength and mobility.
- What could go wrong
- This is a small, early-stage trial (146 participants) testing a non-drug intervention, so results may not be dramatic or apply to everyone. The training requires special equipment and supervision, limiting real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
146 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Aug 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged ≥ 60 years old * Meet the diagnostic criteria of 2019 AWGS2 sarcopenia, can be diagnosed once meeting (1) + (2) or (1) + (3) or (1) + (2) + (3): (1) Appendicular skeletal muscle mass (ASM): dual-energy X-ray absorptiometry (DXA) (male \<7.0 kg/m², female \<5.4 kg/m²). (2) Muscle strength: handgrip strength (male \<28.0 kg, female \<18.0 kg). (3) Physical performance: 6-meter walking speed \<1.0 m/s. * Meet the diagnostic criteria of heart failure following ESC 2021. * Clearly understand the content and purpose of the study and sign the informed consent form. Exclusion Criteria: There are contraindications for Exercise Testing in patients with stable heart failure according to ACSM 2022: * Early stage after acute coronary syndrome (within the first 2 days) * Unstable coronary artery disease * Decompensated heart failure * Acute venous thrombosis or recent arterial embolism (pulmonary or systemic) * Acute myocarditis, pericarditis, endocarditis * Aortic dissection of the valve * Severe symptomatic aortic stenosis * Acute systemic disease or fever * Uncontrolled or life-threatening atrial or ventricular arrhythmias (including new-onset atrial fibrillation or flutter) * Uncontrolled tachycardia (resting heart rate \> 120 beats per minute) * Third-degree AV block * Uncontrolled diabetes * Symptomatic orthostatic hypotension (\> 20 mmHg) * Gradually increasing fatigue during exercise or dyspnea at rest or with exertion within the past 3-5 days * Significant myocardial ischemia at low workloads \< 2 METs or 50W * Relative contraindications according to ACSM 2022: * Weight gain ≥ 1.8 kg in the past 1-3 days * Simultaneous use of continuous or intermittent Dobutamine * Decrease in blood pressure with exercise * NYHA IV heart failure * Complex ventricular arrhythmias at rest or with exertion * Resting heart rate ≥ 100 bpm when lying down * Comorbidities that limit exercise * Severe obstructive hypertrophic cardiomyopathy * Have participated in a cardiovascular rehabilitation program within the last 6 months * Do not agree to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Military Hospital 175
Ho Chi Minh City, 700000, Vietnam
-
University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, 700000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tai chi lift mood and quality of life in older adults losing muscle?
- Can a bone drug also build muscle? trial tests denosumab for sarcopenia
- Can tai chi rebuild strength and balance in aging muscles?
- Can a bone drug rebuild muscle? trial tests denosumab for sarcopenia
- Scientists probe a muscle protein that may hold clues to Age-Related weakness
- A simple pudding might help fight muscle loss in seniors